Navigation Links
Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA
Date:10/27/2008

eillance data examining ceftaroline in vitro activity against isolates from cSSSI and CAP. Ceftaroline was highly active against over 1,500 gram-positive pathogens isolated from cSSSI in the US and Europe, including methicillin-resistant Staphylococcus aureus (MRSA) and fluoroquinolone-resistant streptococci, thus, providing strong support for the use of this agent in the treatment of complicated skin infections. Furthermore, it was found to be highly active against more than 500 community-acquired respiratory tract clinical isolates, including difficult-to-treat antibiotic-resistant strains.(2,3)

--Activities of ceftaroline, ceftobiprole, and cethromycin against multi-drug-resistant (MDR) Streptococcus pneumoniae isolates from Canadian Bacterial Surveillance Network (CBSN) (Poster C1-3843)(4)

Dr. D. Low and colleagues from the Canadian Bacterial Surveillance Network report that three new antibiotics, cethromycin, ceftaroline, and ceftobiprole, have greater in vitro activity against MDRSP than ceftriaxone. Ceftaroline was eight-fold more active than ceftriaxone and four-fold more active than ceftobiprole against these resistant pathogens, supporting its use in potentially life-threatening infections caused by these bacteria.(4)

--In vitro activity of ceftaroline (CPT) vs. vancomycin (VM) against MRSA and hVISA strains in a pharmacokinetic/pharmacodynamic (PK/PD) model (Poster A-979)(5)

--In vitro activity of ceftaroline against CA-MRSA, VISA, VRSA and daptomycin-non-susceptible Staphylococcus aureus (DNSSA) (Poster C1-162)(6)

Dr. C. Vidaillac and colleagues used an in vitro model system to compare the activity of ceftaroline with vancomycin. Ceftaroline was more active against a S. aureus strain with intermediate susceptibility to vancomycin and showed similar or superior activity against MRSA, suggesting that it may provide a new option for the treatment of antibiotic-resistant S. aureus.(5) In support, Dr. L. Saravolatz and colle
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
2. Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer
3. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
4. Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure
5. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
8. Kuvan Receives Positive Opinion From CHMP for European Approval
9. InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
10. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
11. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  The Dr. Samadi Prostate Cancer ... now offering a full suite of new genetic testing methods ... biopsy, for diagnosing prostate cancer. Dr. ... genetic tests for assessing the risk and optimizing the diagnosis ... "We,re very excited to now offer these revolutionary genetic tests ...
(Date:6/30/2015)... ... June 30, 2015 , ... Smarter Alloys today ... revolutionary new archwire that allows orthodontists to simultaneously apply different forces to different ... of SmartArch. “We’re thrilled about taking SmartArch one step closer to commercial availability ...
(Date:6/29/2015)... ... ... This cutting edge standard making is a madatory tool for use in high-end ... the world’s first cuvette-shaped, solid-state filter that lets metrologists and quality control personnel know ... standards, such as those made from didymium glass were only able to operate up ...
(Date:6/29/2015)... KY and Manhattan, KS (PRWEB) , ... June ... ... has acquired US PATENT 7736892 B2. Under the terms of the agreement, MediVet ... Umbilical Cord Matrix Stem Cells (UCMSCs). MB-007 is currently in pre-clinical development as ...
Breaking Biology Technology:New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 2New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 3New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 4New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 5New case studies for SmartArch orthodontic archwire paves way to product launch later this year 2FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 2FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 3MediVet Biologics Acquires Exclusive Patent License from Kansas State University 2MediVet Biologics Acquires Exclusive Patent License from Kansas State University 3
... Roles as Vice Chairman of The Foundry and Advisor to ForSight ... ... Labs, MENLO PARK, Calif., Sept. 4 Morgenthaler Ventures, (http://www.morgenthaler.com/ventures ... technology investments, today announced the,addition of Hank Plain as partner in ...
... PRINCETON, N.J., Sept. 4 Medarex, Inc.,(Nasdaq: MEDX ... at the Bear,Stearns 20th Annual Healthcare Conference at 9:00 ... is being held at The Grand Hyatt,New York in ... and,will be available for replay through the Webcast page ...
... Paves the Way for the Phase III Clinical ... Commercialization of THR-100 in Developing ... NV (Euronext,Brussels: THR), a biotechnology company focused on ... technology transfer to Bharat,Biotech International Limited (Hyderabad, India) ...
Cached Biology Technology:Hank Plain Joins Morgenthaler Ventures as Partner 2Hank Plain Joins Morgenthaler Ventures as Partner 3Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 4
(Date:6/30/2015)... 30, 2015 To bolster its efforts and commitment ... announced today the addition of two new team members. ... advisor and David Raviv will act as head ... Corp.,s commitment to providing the most secure solutions for the ... co-founded Layer 7 Technologies, a provider of security and management ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... as CEO to help further develop Genisphere,s therapeutics capabilities ... partnering experience, having spent much of the last 25 ... Amgen, Baxter Bioscience, and Johnson & Johnson. Tom started ... Technology and Biotech Corporate Finance. He graduated from Dartmouth ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Latin America Biomedical Sensors Market Report 2015-2020 2
... CITY While researching new ways to stop the ... Health Sciences Center, have discovered a compound that has ... appears in the journal Gene Regulation and Systems Biology. ... clinical trials, successfully stopped normal cells from turning into ...
... gel electrophoresis" Most teenagers wouldnt have a clue what ... Trigiano knows the protocol inside and out. When Andrew ... the University of Tennessee, was looking for an interesting ... differences in popular brands of Easter egg dyes, Trigianos ...
... will help archeologist Bill Middleton peer into the ancient ... hyperspectral data will help build the most accurate and ... state of Oaxaca, where the Zapotec people formed the ... you ask someone off the street about Mexican archeology, ...
Cached Biology News:Chemical compound prevents cancer in lab 2DNA fingerprinting simplified 2Archaeologist uses satellite imagery to explore ancient Mexico 2Archaeologist uses satellite imagery to explore ancient Mexico 3
Mouse Laminin-1 MAb (Clone AL-3)...
Anti-Potassium Channel EAG-1 Immunogen: Synthetic peptide from the C-terminus of rat Kv10.1 (Accession Q63472). The immunogen sequence is identical in mouse and 14/16 residues identical in human...
IEX-1 S/L (H-20)...
WIF-1 (N-20)...
Biology Products: